Page 7 of 8
Journal of the American Chemical Society
Hewavitharan, A. K.; Chen, D. D.Y. J. Chromatogr. A 2012, 1267, 162–
169.
(6) Miziorko, H. M. Arch. Biochem. Biophys. 2011, 505, 131–143.
(7) Fernstrom, J. D.; Fernstrom, M. H. J. Nutr. 2007, 137, 1539S–1547S.
(8) (a) Hirai, T.; Matsumoto, S.; Kishi, I. J. Chromatogr. B 1997, 692,
375–388. (b) Aresta, A.; Palmisano, F.; Zambonin, C. G.; J. Pharm. Bio-
med. Anal. 2005, 39, 643–647.
Station 4000MM PRO (for qualitative and semi-quantitative ex-
periments). The images recorded using the Image Station
4000MM PRO reflect both fluorescence (11 channels) and color
intensity (four channels), respectively. In fluorescence detection,
1
2
3
4
5
6
7
8
the combinations of channels (excitation (λex) and emission (λem
)
filters) are: λex(430 nm)-λem(480 nm), λex(430 nm)-λem(535 nm),
λex(430 nm)-λem(600 nm), λex(470 nm)-λem(535 nm), λex(470 nm)-
λem(600 nm), λex(500 nm)-λem(535 nm), and λex(500 nm)- λem(600
nm). No excitation filters were used when using broadband UV as
excitation light, and the combinations of channels are: λex(UV)-
λem(440 nm), λex(UV)-λem(535 nm), λex(UV)-λem(480 nm), and
λex(UV)-λem(600 nm). In colorimetric detection using the
4000MM PRO, the filters for color-intensity measurement are 440,
480, 535, and 600 nm, respectively. After acquiring the images, the
integrated (non-zero) grey pixel value (n) is calculated for each
well in each channel. Images of the sensor chip were recorded be-
fore (b) and after (a) the addition of an analyte. The final responses
(R) were evaluated as indicated in the following equation (1):
(9) Maurer, H. H.; Tauvel, F. X.; Kraemer, T. J. Anal. Toxicol. 2001, 25,
237–244.
(10) (a) Sessler, J. L.; Gale, P.A.; Cho, W.-S. Anion Receptor Chemistry.
Monographs in supramolecular Chemistry; Royal Society of Chemistry:
Cambridge, 2006. (b) Bayly, S. R.; Beer, P. D. Struct. Bond. 2008, 129, 45–
94. (c) Valeria, A.; Fabbrizzi, L.; Mosca, L. Chem. Soc. Rev. 2010, 39,
3889–3915. (d) Duke, R. M.; Veale, E. B.; Pfeffer, F. M.; Kruger, P. E.;
Gunnlaugsson, T. Chem. Soc. Rev. 2010, 39, 3936–3953. (e) Li, A.-F.;
Wang, J.-H.; Wang, F.; Jiang, Y.-B. Chem. Soc. Rev. 2010, 39, 3729–3745.
(f) Wenzel, M.; Hiscock, J. R.; Gale, P. A. Chem. Soc. Rev. 2012, 41, 480–
520. (g) Ngo, H. T.; Liu, X.; Jolliffe, K. A. Chem. Soc. Rev. 2012, 41, 4928–
4965. (h) Pal, R.; Beeby, A.; Parker, D. J. Pharm. Biomed. Anal. 2011, 56,
352–358. (i) Butler, S. J.; Parker, D. Chem. Soc. Rev. 2013, 42, 1652–1666.
(11) (a) Gardner, J. W.; Bartlett, P. N. Electronic Noses: Principles and
Applications; Oxford University Press: New York, 1999. (b) Rakow, N. A.;
Suslick, K. S. Nature 2000, 406, 710–714. (c) Albert, K. J.; Lewis, N. S.;
Schauer, C. L.; Sotzing, G. A.; Stitzel, S. E.; Vaid, T. P.; Walt, D. R. Chem.
Rev. 2000, 100, 2595–2626. (d) Lavigne, J. J.; Anslyn, E. V. Angew. Chem.
Int. Ed. 2001, 40, 3118–3130. (e) Anzenbacher, P., Jr.; Lubal, P.; Bucek, P.;
Palacios, M. A.; Kozelkova, M. E. Chem. Soc. Rev. 2010, 39, 3954–3979.
(f) Paolesse, R.; Monti, D.; Dini, F.; Di Natale, C. Top. Curr. Chem. 2011,
300, 139–174. (g) Stitzel, S. E.; Aernecke, M. J.; Walt, D. R. Annu. Rev.
Biomed. Eng. 2011. 13, 1–25.
(12) (a) Nelson, T. L.; O’Sullivan, C.; Greene, N. T.; Maynor, M.S.;
Lavigne, J. J. J. Am. Chem. Soc. 2006, 128, 5640-5641. (b)Palacios, M. A.;
Nishiyabu, R.; Marquez, M.; Anzenbacher, P., Jr. J. Am. Chem. Soc. 2007,
129, 7538-7544. (c) Lavigne, J. J. Nat. Mater. 2007, 6, 548–549. (d) Pala-
cios, M. A.; Wang, Z.; Montes, V. A.; Zyryanov, G.V.; Hausch, B. J.;
Jursıkova, K. Anzenbacher, P., Jr. Chem. Commun. 2007, 3708–3710. (e)
Zyryanov, G. V.; Palacios, M. A.; Anzenbacher, P., Jr. Angew. Chem. Int. Ed.
2007, 46, 7849–7852. (f) Wang, Z.; Palacios, M. A.; Zyryanov, G. V.;
Anzenbacher, P., Jr. Chem. –Eur. J. 2008, 14, 8540–8546. (g) Wang, Z.;
Palacios, M. A.; Anzenbacher, P., Jr. Anal. Chem. 2008, 80, 7451–7459. (h)
Palacios, M. A.; Wang, Z.; Montes, V. A.; Zyryanov, G. V.; Anzenbacher, P.,
Jr. J. Am. Chem. Soc. 2008, 130, 10307–10314. (i) Shabbir, S. H.; Joyce, L.
A.; da Cruz, G. M.; Lynch, V. M.; Sorey, S.; Anslyn, E. V. J. Am. Chem. Soc.
2009, 131, 13125–13131. (j) Suslick, B. A.; Feng, L.; Suslick, K. S.; Anal.
Chem. 2010, 82, 2067–2073. (k) Liu, Y.; Palacios, M. A.; Anzenbacher, P.,
Jr. Chem. Commun. 2010, 46, 1860–1862. (l) Feng, L.; Zhang, Y.; Wen, L.
Y.; Chen, L.; Shen, Z.; Guan, Y. F. Chem. –Eur. J. 2011, 17, 1101–1104.
(m) Davey, E. A.; Zucchero, A. J.; Trapp, O.; Bunz, U. H. F. J. Am. Chem.
Soc. 2011, 133, 7716–7718. (n) Lin, H.; Jang, M.; Suslick, K. S. J. Am.
Chem. Soc. 2011, 133, 16786–16789. (o) Zhang, X.; You, L.; Anslyn, E. V.;
Qian, X. Chem. –Eur. J. 2012, 18, 1102–1110. (p) Anzenbacher, P., Jr.; Li,
F.; Palacios, M. A. Angew. Chem. Int. Ed. 2012, 51, 2345–2348. (q) Lim, J.;
Nam, D.; Miljanić , O. Š.; Chem. Sci. 2012, 3, 559–563. (r) Minami, T.;
Esipenko, N. A.; Zhang, B.; Kozelkova, M. E.; Isaacs, L.; Nishiyabu, R.;
Kubo, Y.; Anzenbacher, P., Jr. J. Am. Chem. Soc. 2012, 134, 20021–20024.
(13) Kitamura, M.; Shabbir, S. H.; Anslyn, E. V. J. Org. Chem. 2009, 74,
4479–4489.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
an
(1)
R
1
b
n
n
ASSOCIATED CONTENT
Supporting Information
Synthesis and characterization of S3, S4, S5, S6, and S7, UV-vis and
fluorescence spectra, results of multivariate analysis. This material is
AUTHOR INFORMATION
Corresponding Author
ACKNOWLEDGMENT
We gratefully acknowledge the financial support from the NSF (CHE-
0750303 and EXP-LA 0731153 to P.A.) and BGSU (TIE Grant).
REFERENCES
(1) (a) Kroschwitz, J. I.; Seidel, A. Kirk-Othmer Encyclopedia of Chemi-
cal Technology, 5th ed., Vol. 5; Wiley-Interscience: Hoboken, N. J.: New
Chemistry, 7th ed.; Wiley-VCH: Weinheim, 2011.
(2) (a) Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and
Clinical Uses, 2nd ed.; Lewis, A. J.; Furst, D. E., Eds. Marcel Dekker: New
York, 1994; (b) Lemke, T. L. Williams, D. A. Nonsteroidal anti-
inflammatory drugs Foye's Principles of Medicinal Chemistry, 6th ed.;
Lippincott Williams&Wilkins: Philadelphia, 2008. (c) Pharmacotherapy
Handbook, 8th ed.; Wells, B. G.; DiPiro, J. T.; Schwinghammer, T. L.;
DiPiro, C. Eds. McGraw Hill: New York, 2012.
(3) (a) Corcoran, J.; Winter, M. J.; Tyler, C. R. Crit. Rev. Toxicol.
summary.htm
(14) Nishiyabu, R.; Anzenbacher, P., Jr. J. Am. Chem. Soc. 2005, 127,
8270–8271.
(4) Li, Q.; Weina, P. Pharmaceuticals 2010, 3, 2322–2332.
(15) Reviews see: (a) Gale, P. A.; Anzenbacher, P., Jr. Sessler, J. L. Coord.
Chem. Rev. 2001, 222, 57–102. (b) P. Anzenbacher Jr., Top. Heterocycl.
Chem. 2010, 24, 205–235. (c) Anzenbacher, P., Jr. Top. Heterocycl. Chem.
2010, 24, 237–265. Examples see: (d) Miyaji, H.; Sato, W.; Sessler, J. L.
Angew. Chem. Int. Ed. 2000, 39, 1777–1780. (e) Nielsen, K. A.; Jeppesen, J.
O.; Levillain, E.; Becher, J. Angew. Chem. Int. Ed. 2003, 42, 187–191. (f)
Nishiyabu, R.; Anzenbacher, P., Jr. Org. Lett. 2006, 8, 359–362. (g)
Sokkalingam, P.; Kim, D. S.; Hwang, H.; Sessler, J. L.; Lee, C.-H. Chem. Sci.
2012, 3, 1819–1824.
(5) (a) Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.;
Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.;
Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.;
Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei,
J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Nature 2009, 457,
910–914. (b) Wu, H.; Liu, T.; Ma, C.; Xue, R.; Deng, C.; Zeng, H.; Shen,
X. Anal. Bioanal. Chem. 2011, 401, 635–646. (c) Solimana, L. C.; Hui, Y.;
ACS Paragon Plus Environment